Drug manufacturers to focus on China and Japan, where penetration is low and innovation continues to emerge, Morgan Stanley ...

Eli Lilly (NYSE ... although it was approved only in late 2023. Zepbound's prospects still look bright, but some recent developments point to another weight loss drug that could become yet ...

Eli Lilly, the drugmaker behind the blockbuster weight loss drug ... never been approved by the FDA. "Fella even tells patients that its untested oral drug is better than Lilly's approved ...

The market for weight-loss drugs could see new entrants among existing biotech firms, with several drug candidates likely to be approved ... s obesity market will grow, particularly in China ...

Eli Lilly, the drugmaker behind the blockbuster weight loss ... available drug. Mochi representatives did not respond to requests for comment. Lilly's complaint against Henry Meds alleges the ...

Rather, they are essentially copies that are allowed to be made by special pharmacies called compounding pharmacies during drug ... approved any form of tirzepatide for cosmetic weight loss ...